MarginsXMarginsX
Home › Markets › BIOE

Bio Essence Corp (BIOE)

BIOE is quoted over the counter, not listed on an exchange. Bio Essence Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.4700
0.0% on the day
1-year return
+710.3%
Market cap
$25.3M
Nano cap. From the Nov 13, 2026 close × 53.8M shares (10-Q cover page, Nov 12, 2026)
P/E and P/S
18.7× · 8.4×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerBIOE, quoted over the counter
SEC CIK0001723059
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressIrvine, CA
Incorporated inCA

Warning signs

Cash runway
Cash-flow positive
$202K cash at September 30, 2026
Share count, 1 year
+41.6%
2025-11-15 to 2026-11-12 · +41.6% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$202K cash; operating cash flow $130K a quarter.Report 2026-09-30
Shares outstanding53,809,000 (2026-11-12); 38,009,000 a year earlier; 38,009,000 three years earlier.Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSimon & Edward, LLP, Rowland Heights, California, United StatesPCAOB Form AP 2026-04-07
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$253K-$150K-$369K$202K$57K$3.0M10-Q 2026-11-13
Q2 2026
2026-06-30
$795K$270K$60K$675$57K$2.9M10-Q 2026-08-14
Q1 2026
2026-03-31
$501K$205K-$412K$36K$57K$2.4M10-Q 2026-05-15
Q4 2025
2025-12-31
$1.5M$1.0M$1.2MNot filed$57K$1.9M10-K 2026-03-27
Q3 2025
2025-09-30
$137K$13K$187K$29K$58K$566K10-Q 2026-11-13
Q2 2025
2025-06-30
$259K$60K$168KNot filed$58K$564K10-Q 2026-08-14
Q1 2025
2025-03-31
$22K-$206K-$26KNot filed$56K$346K10-Q 2026-05-15
Q4 2024
2024-12-31
$148K-$28K$423K$1K$56K$324K10-K 2026-03-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document1-A2025-10-17
Latest annual report10-K2026-03-27
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-10-23

Source: SEC EDGAR submissions feed, 88 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier